Cartesian Therapeutics Inc. (NASDAQ: RNAC)
$18.9700
-0.0500 ( -0.18% ) 0.0K
Cartesian Therapeutics Inc is a clinical-stage biopharmaceutical company. The company uses its ImmTOR immune tolerance platform, which is designed to give rise to antigen-specific immunity, mitigating unwanted immune responses. It leverages its proprietary technology and manufacturing platform to introduce one or more mRNA molecules into cells to enhance their function. Unlike DNA, mRNA degrades naturally over time without integrating into the cell's genetic material.
Market Data
Open
$18.9700
Previous close
$19.0200
Volume
0.0K
Market cap
$483.39M
Day range
$19.0050 - $19.0050
52 week range
$11.6650 - $41.8700
SEC Filings
Form Type | Description | Pages | Date |
---|---|---|---|
4 | Insider transactions | 1 | Dec 11, 2024 |
8-k | 8K-related | 34 | Dec 03, 2024 |
4 | Insider transactions | 1 | Nov 21, 2024 |
4 | Insider transactions | 1 | Nov 21, 2024 |
4 | Insider transactions | 1 | Nov 21, 2024 |
4 | Insider transactions | 1 | Nov 18, 2024 |
4 | Insider transactions | 1 | Nov 18, 2024 |
4 | Insider transactions | 1 | Nov 18, 2024 |
4 | Insider transactions | 1 | Nov 18, 2024 |
10-q | Quarterly Reports | 107 | Nov 07, 2024 |